Diadema Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Buy
94,042
+31,795
+51% +$4M 3.6% 4
2025
Q1
$6.88M Buy
+62,247
New +$6.88M 1.8% 6